NCT03191149 2026-03-18
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
National Cancer Institute (NCI)
Phase 2 Recruiting
National Cancer Institute (NCI)
Rutgers, The State University of New Jersey
M.D. Anderson Cancer Center